National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

tetanus-CMV fusion peptide vaccine
A vaccine containing an inactivated epitope of tetanus toxin fused to a cytomegalovirus (CMV) peptide epitope, with potential anti-viral and immunomodulating activities. Upon administration, tetanus-CMV fusion peptide may stimulate a cytotoxic T-lymphocyte (CTL) response against CMV in the CMV-infected host. Tetanus toxin contains universal T cell helper epitopes. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:Testostroval-PA, Testro AQ, tetanus peptide melanoma vaccine, tetanus toxoid, tetanus toxoid helper peptide
Next:tetracycline antibiotic, tetracycline hydrochloride, tetradecanoylphorbol acetate, tetrahydrouridine, tetrodotoxin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov